← Eichor
Study identifier: NCT06773988 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Follow-up of NIV At Home in Patients with Duchenne Muscular Dystrophy

Condition: Duchenne Muscular Dystrophy (DMD)  ·  Sponsor: Universitaire Ziekenhuizen KU Leuven

PhaseN/A
Planned participants17
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The aim of this study is to verify whether full video home polysomnography (sleep study) with nocturnal transcutaneous CO2 monitoring is feasible in the follow-up of non-invasive ventilation (NIV) in patients with Duchenne muscular dystrophy. The researchers would like to investigate whether they could perform sufficient measurements in the home situation and see if correct decision for further treatment could be made. Furthermore, the researchers will make an analysis on the minimal requirements of measurements to make a correct decision for the treatment of these patients.

This description comes directly from the study's public registry record.

Talk to the study team

Dries Testelmans, MD PHD  ·  +3216342522  ·  dries.testelmans@uzleuven.be

Bart Vrijsen, PT PHD  ·  +3216342522  ·  bart.vrijsen@uzleuven.be

Always discuss trial participation with your own doctor first.

Locations (1)

Universitaire Ziekenhuizen KU LeuvenLeuven, Vlaams-Brabant, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06773988